Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Anti-EGF antibodies as surrogate biomarkers of clinical efficacy in stage IIIB/IV non-small-cell lung cancer patients treated with an optimized CIMAvax-EGF vaccination schedule.
Journal: Oncoimmunology
Published: September 14, 2020
Differential effects of two therapeutic cancer vaccines on short- and long-term survival populations among patients with advanced lung cancer.
Journal: Seminars in oncology
Published: April 15, 2018
CIMAvax EGF (EGF-P64K) vaccine for the treatment of non-small-cell lung cancer.
Journal: Expert review of vaccines
Published: August 22, 2015
Therapeutic Targeting of CD6 in Autoimmune Diseases: A Review of Cuban Clinical Studies with the Antibodies IOR-T1 and Itolizumab.
Journal: Current drug targets
Published: July 21, 2015
A Phase III Clinical Trial of the Epidermal Growth Factor Vaccine CIMAvax-EGF as Switch Maintenance Therapy in Advanced Non-Small Cell Lung Cancer Patients.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 08, 2015
Challenges and opportunities for cancer vaccines in the current NSCLC clinical scenario.
Journal: Current topics in medicinal chemistry
Published: November 30, 2012
Showing 1-7 of 7
Last Updated: 09/26/2026